Last updated: June 4, 2025
Sponsor: University of Alabama at Birmingham
Overall Status: Active - Recruiting
Phase
N/A
Condition
Musculoskeletal Diseases
Treatment
Quad tendon
BTB
Clinical Study ID
NCT05461326
IRB-300009203
Ages 14-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Skeletally mature patients younger 65
ACL insufficiency
Scheduled to undergo autograft ACL reconstruction
Appropriate candidate for autograft harvest
Exclusion
Exclusion Criteria:
<14 or 65>
Poor autograft candidate (poor tissue quality)
Multi ligamentous reconstruction (PCL, MCL, or PLC)
Pregnant or nursing
High likelihood of remaining non-compliant with physical therapy regimen
Desire to return to sport prior to 6 months
Inability to read and write English
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Quad tendon
Phase:
Study Start date:
September 26, 2023
Estimated Completion Date:
June 30, 2030
Study Description
Connect with a study center
UAB Hospital Highlands
Birmingham, Alabama 35205
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.